Planning and managing clinical trials is an increasingly complex task. Unlike standard supply chains, there are many unpredictable factors. We are fostering our capabilities in Clinical Trial Materials supply chain management, providing our clients with the best and most comprehensive service offerings in the marketplace.
A clinical trial is an intervention study – a particular kind of clinical research study that aims to answer the question about treatment. The treatment under investigation can be a new drug, medical device, or behavior. The question is usually about the safety or efficacy of the intervention.
A long process of preclinical research precedes a clinical trial. Initially, the intervention is studied in the lab. These tests begin in labs and often involve toxicity screening. Then they will progress to animals( as mice or ferrets) for further toxicity and safety testing and to collect initial efficacy outcomes. After preclinical research, if the intervention appears promising, it will enter into the 5 phases of the clinical trial:
Ikris Pharma International (IPI) facilitates comparator drug supply worldwide. IPI has expertise in sourcing Reference Listed Drugs or Innovator drugs samples from across the globe, including India, USA, Europe, Canada, Australia, New Zealand, Korea, Japan, and Latin America.
With increasing demands for numerous treatments for rare, new, and chronic diseases, the healthcare and pharmaceutical industry looks forward to developing innovative drugs and generic versions of the innovator drugs. Drug developers prepare for clinical trials to fill this demand and supply void within a reasonable cost. Clinical trials are a key research tool for advancing medical knowledge and patient care. Clinical research is done when doctors do not know whether a new approach works well in people and is safe and which treatments or strategies work best for certain illnesses or groups. Clinical trials play a crucial part in developing new therapeutics and vaccines, allowing drug manufacturers to evaluate the safety and efficacy of new medicines in a controlled manner.
Through our Clinical Trial Sourcing services, Ikris Pharma Network (IPN) supports biopharmaceutical research and development efforts globally. IPN excels in procuring and delivering a wide range of pharmaceuticals and ancillary clinical supplies for clinical trial and drug development programs. As the complexity of clinical trials increases, trial sponsors must form strategic relationships to ensure a reliable supply of all needed clinical trial materials, including sourcing RLDs. Ikris Pharma is committed to the sourcing and supply of commercial medicines across all therapeutic areas. Our highly skilled and dedicated account managers are experts in offering reliable market information and an in-depth understanding of the clinical trial landscape and helping manage sourcing requests to stay ahead of sponsors' requirements proactively. IPN specializes in sourcing Reference Listed Drugs/ Innovator samples from across the globe, including India, the USA, Europe, Canada, Australia, New Zealand, Korea, Japan, and Latin America.